197 related articles for article (PubMed ID: 34839358)
1. ONECUT2 facilitates hepatocellular carcinoma metastasis by transcriptionally upregulating FGF2 and ACLY.
Liu D; Zhang T; Chen X; Zhang B; Wang Y; Xie M; Ji X; Sun M; Huang W; Xia L
Cell Death Dis; 2021 Nov; 12(12):1113. PubMed ID: 34839358
[TBL] [Abstract][Full Text] [Related]
2. SIX4 promotes hepatocellular carcinoma metastasis through upregulating YAP1 and c-MET.
He Q; Lin Z; Wang Z; Huang W; Tian D; Liu M; Xia L
Oncogene; 2020 Dec; 39(50):7279-7295. PubMed ID: 33046796
[TBL] [Abstract][Full Text] [Related]
3. ATP citrate lyase inhibitor triggers endoplasmic reticulum stress to induce hepatocellular carcinoma cell apoptosis via p-eIF2α/ATF4/CHOP axis.
Zheng Y; Zhou Q; Zhao C; Li J; Yu Z; Zhu Q
J Cell Mol Med; 2021 Feb; 25(3):1468-1479. PubMed ID: 33393219
[TBL] [Abstract][Full Text] [Related]
4. IGF1-mediated HOXA13 overexpression promotes colorectal cancer metastasis through upregulating ACLY and IGF1R.
Qiao C; Huang W; Chen J; Feng W; Zhang T; Wang Y; Liu D; Ji X; Xie M; Sun M; Fan D; Wu K; Xia L
Cell Death Dis; 2021 Jun; 12(6):564. PubMed ID: 34075028
[TBL] [Abstract][Full Text] [Related]
5. ATP-citrate lyase regulates stemness and metastasis in hepatocellular carcinoma via the Wnt/β-catenin signaling pathway.
Han Q; Chen CA; Yang W; Liang D; Lv HW; Lv GS; Zong QN; Wang HY
Hepatobiliary Pancreat Dis Int; 2021 Jun; 20(3):251-261. PubMed ID: 33129711
[TBL] [Abstract][Full Text] [Related]
6. Homeobox B5 promotes metastasis and poor prognosis in Hepatocellular Carcinoma, via FGFR4 and CXCL1 upregulation.
He Q; Huang W; Liu D; Zhang T; Wang Y; Ji X; Xie M; Sun M; Tian D; Liu M; Xia L
Theranostics; 2021; 11(12):5759-5777. PubMed ID: 33897880
[No Abstract] [Full Text] [Related]
7. Interleukin 1β-mediated HOXC10 Overexpression Promotes Hepatocellular Carcinoma Metastasis by Upregulating PDPK1 and VASP.
Dang Y; Chen J; Feng W; Qiao C; Han W; Nie Y; Wu K; Fan D; Xia L
Theranostics; 2020; 10(8):3833-3848. PubMed ID: 32206125
[No Abstract] [Full Text] [Related]
8. T-box transcription factor 19 promotes hepatocellular carcinoma metastasis through upregulating EGFR and RAC1.
Ji X; Chen X; Zhang B; Xie M; Zhang T; Luo X; Liu D; Feng Y; Wang Y; Sun M; Li C; Huang W; Xia L
Oncogene; 2022 Apr; 41(15):2225-2238. PubMed ID: 35217793
[TBL] [Abstract][Full Text] [Related]
9. FOXC1 promotes HCC proliferation and metastasis by Upregulating DNMT3B to induce DNA Hypermethylation of CTH promoter.
Lin Z; Huang W; He Q; Li D; Wang Z; Feng Y; Liu D; Zhang T; Wang Y; Xie M; Ji X; Sun M; Tian D; Xia L
J Exp Clin Cancer Res; 2021 Feb; 40(1):50. PubMed ID: 33522955
[TBL] [Abstract][Full Text] [Related]
10. HOXB7 promotes tumor progression via bFGF-induced activation of MAPK/ERK pathway and indicated poor prognosis in hepatocellular carcinoma.
Wang WM; Xu Y; Wang YH; Sun HX; Sun YF; He YF; Zhu QF; Hu B; Zhang X; Xia JL; Qiu SJ; Zhou J; Yang XR; Fan J
Oncotarget; 2017 Jul; 8(29):47121-47135. PubMed ID: 28454092
[TBL] [Abstract][Full Text] [Related]
11. Comprehensive profiling of novel microRNA-9 targets and a tumor suppressor role of microRNA-9 via targeting IGF2BP1 in hepatocellular carcinoma.
Zhang J; Cheng J; Zeng Z; Wang Y; Li X; Xie Q; Jia J; Yan Y; Guo Z; Gao J; Yao M; Chen X; Lu F
Oncotarget; 2015 Dec; 6(39):42040-52. PubMed ID: 26547929
[TBL] [Abstract][Full Text] [Related]
12. MiR-195 is a key negative regulator of hepatocellular carcinoma metastasis by targeting FGF2 and VEGFA.
Wang M; Zhang J; Tong L; Ma X; Qiu X
Int J Clin Exp Pathol; 2015; 8(11):14110-20. PubMed ID: 26823724
[TBL] [Abstract][Full Text] [Related]
13. Activation of ACLY by SEC63 deploys metabolic reprogramming to facilitate hepatocellular carcinoma metastasis upon endoplasmic reticulum stress.
Hu C; Xin Z; Sun X; Hu Y; Zhang C; Yan R; Wang Y; Lu M; Huang J; Du X; Xing B; Liu X
J Exp Clin Cancer Res; 2023 May; 42(1):108. PubMed ID: 37122003
[TBL] [Abstract][Full Text] [Related]
14. H2.0-like homeobox 1 acts as a tumor suppressor in hepatocellular carcinoma.
Liu T; Chen J; Xiao S; Lei X
Tumour Biol; 2016 May; 37(5):6419-28. PubMed ID: 26631039
[TBL] [Abstract][Full Text] [Related]
15. PRRX1 deficiency induces mesenchymal-epithelial transition through PITX2/miR-200-dependent SLUG/CTNNB1 regulation in hepatocellular carcinoma.
Chen W; Wu J; Shi W; Zhang G; Chen X; Ji A; Wang Z; Wu J; Jiang C
Cancer Sci; 2021 Jun; 112(6):2158-2172. PubMed ID: 33587761
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of forkhead box C1 promotes tumor metastasis and indicates poor prognosis in hepatocellular carcinoma.
Xia L; Huang W; Tian D; Zhu H; Qi X; Chen Z; Zhang Y; Hu H; Fan D; Nie Y; Wu K
Hepatology; 2013 Feb; 57(2):610-24. PubMed ID: 22911555
[TBL] [Abstract][Full Text] [Related]
17. Sox12, a direct target of FoxQ1, promotes hepatocellular carcinoma metastasis through up-regulating Twist1 and FGFBP1.
Huang W; Chen Z; Shang X; Tian D; Wang D; Wu K; Fan D; Xia L
Hepatology; 2015 Jun; 61(6):1920-33. PubMed ID: 25704764
[TBL] [Abstract][Full Text] [Related]
18. EB2 promotes hepatocellular carcinoma proliferation and metastasis via MAPK/ERK pathway by modulating microtubule dynamics.
Zhong FJ; Li YM; Xu C; Sun B; Wang JL; Yang LY
Clin Sci (Lond); 2021 Apr; 135(7):847-864. PubMed ID: 33755094
[TBL] [Abstract][Full Text] [Related]
19. [Expression and Clinical Significance of ATP Citrate Lyase in Hepatocellular Carcinoma].
Yu HJ; Wei LY; Liu SS; Zhang ZT; Guan CJ
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2023 Oct; 45(5):743-751. PubMed ID: 37927015
[TBL] [Abstract][Full Text] [Related]
20. Role of IQGAP3 in metastasis and epithelial-mesenchymal transition in human hepatocellular carcinoma.
Shi Y; Qin N; Zhou Q; Chen Y; Huang S; Chen B; Shen G; Jia H
J Transl Med; 2017 Aug; 15(1):176. PubMed ID: 28810875
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
